DXCM
$66.29
Revenue | $1259.6Mn |
Net Profits | $267.3Mn |
Net Profit Margins | 21.22% |
Dexcom, Inc.’s revenue jumped 13.12% since last year same period to $1259.6Mn in the Q4 2025. On a quarterly growth basis, Dexcom, Inc. has generated 4.16% jump in its revenue since last 3-months.
Dexcom, Inc.’s net profit jumped 76.2% since last year same period to $267.3Mn in the Q4 2025. On a quarterly growth basis, Dexcom, Inc. has generated -5.81% fall in its net profits since last 3-months.
Dexcom, Inc.’s net profit margin jumped 55.77% since last year same period to 21.22% in the Q4 2025. On a quarterly growth basis, Dexcom, Inc. has generated -9.58% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.47 |
EPS Estimate Current Year | 0.47 |
Dexcom, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.47 - a -27.38% fall from last quarter’s estimates.
Dexcom, Inc.’s earning per share (EPS) estimates for the current year stand at 0.47.
Earning Per Share (EPS) | 0 |
Dexcom, Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Dexcom, Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-04-23 | 0.47 | 0 | -100% |